Table 3.

The health of the patients who became eligible for antifungal pharmacotherapy in group Newton 0 and Newton 1, 2 or 3.

Disease	Newton 0	Newton 1,2,3	OR	p
Hypertension	20 (22%)	32 (17%)	0.728	0.32
Cardiovascular diseases	4 (4%)	18 (10%)	2.303	0.142
Diabetes	7 (8%)	7 (4%)	0.464	0.163
Asthma	2 (2%)	2 (1%)	0.478	0.465
Ulcers	1 (1%)	1 (1%)	0.481	0.607